These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9583632)

  • 21. Dimensions underlying legislator support for tobacco control policies.
    de Guia NA; Cohen JE; Ashley MJ; Ferrence R; Rehm J; Studlar DT; Northrup D
    Tob Control; 2003 Jun; 12(2):133-9. PubMed ID: 12773721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How tobacco companies use the revolving door between government and industry to influence policymaking: an Australian case study.
    Watts C; Jones M; Lindorff K; Freeman B
    Public Health Res Pract; 2023 Dec; 33(4):. PubMed ID: 37164761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of state legislators' intentions to vote for cigarette tax increases.
    Flynn BS; Goldstein AO; Solomon LJ; Bauman KE; Gottlieb NH; Cohen JE; Munger MC; Dana GS
    Prev Med; 1998; 27(2):157-65. PubMed ID: 9578987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can lobbyists represent tobacco and health?
    Pallarito K
    Mod Healthc; 1993 Mar; 23(12):20. PubMed ID: 10124742
    [No Abstract]   [Full Text] [Related]  

  • 25. Public opinion and legislators' views on tobacco policy.
    Hahn EJ; Rayens MK
    J Ky Med Assoc; 2000 Feb; 98(2):67-73. PubMed ID: 10703187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Legislators' beliefs on tobacco control policies in Nevada.
    York NL; Pritsos CA; Gutierrez AP
    J Community Health; 2012 Feb; 37(1):89-95. PubMed ID: 21644023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tobacco Institute lobbying at the state and local levels of government in the 1990s.
    Morley CP; Cummings KM; Hyland A; Giovino GA; Horan JK
    Tob Control; 2002 Mar; 11 Suppl 1(Suppl 1):I102-9. PubMed ID: 11893820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tobacco control interest groups and their influence on parliamentary committees in Canada.
    Hastie RE; Kothari AR
    Can J Public Health; 2009; 100(5):370-5. PubMed ID: 19994741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "A phony way to show sincerity, as we all well know": tobacco industry lobbying against tobacco control in Hong Kong.
    Knight J; Chapman S
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii13-21. PubMed ID: 15564215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revealing the link between campaign financing and deaths caused by tobacco.
    Califano JA
    JAMA; 1994 Oct; 272(15):1217-8. PubMed ID: 7933353
    [No Abstract]   [Full Text] [Related]  

  • 31. Campaign contributions from the American Medical Political Action Committee to Members of Congress. For or against the public health?
    Sharfstein JM; Sharfstein SS
    N Engl J Med; 1994 Jan; 330(1):32-7. PubMed ID: 8018142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tobacco industry strategy to undermine tobacco control in Finland.
    Hiilamo H
    Tob Control; 2003 Dec; 12(4):414-23. PubMed ID: 14660780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The implementation and enforcement of tobacco control laws: policy implications for activists and the industry.
    Jacobson PD; Wasserman J
    J Health Polit Policy Law; 1999 Jun; 24(3):567-98. PubMed ID: 10386327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lobbying: the best kind can be self-taught.
    Rose CE
    Pa Med; 1992 May; 95(5):22-3. PubMed ID: 1603591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tobacco industry campaign contributions in Ontario, 1990-95.
    Alexander DL; Cohen JE; Ferrence RG; Ashley MJ; Northrup DA; Pollard JS
    Can J Public Health; 1997; 88(4):230-1. PubMed ID: 9336090
    [No Abstract]   [Full Text] [Related]  

  • 36. Consensus for tobacco policy among former state legislators using the policy Delphi method.
    Hahn EJ; Rayens MK
    Tob Control; 1999; 8(2):137-40. PubMed ID: 10478396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "My good friends on the other side of the aisle aren't bothered by those facts": U.S. State legislators' use of evidence in making policy on abortion.
    Woodruff K; Roberts SCM
    Contraception; 2020 Apr; 101(4):249-255. PubMed ID: 31881221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revealing and reversing tobacco industry strategies.
    Fielding JE
    Am J Public Health; 1996 Aug; 86(8):1073-5. PubMed ID: 8712260
    [No Abstract]   [Full Text] [Related]  

  • 39. Support for tobacco control policies: how congruent are the attitudes of legislators and the public?
    de Guia NA; Cohen JE; Ashley MJ; Pederson L; Ferrence R; Bull S; Northrup D; Poland B
    Can J Public Health; 2003; 94(1):36-40. PubMed ID: 12583669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tobacco industry allegations of "illegal lobbying" and state tobacco control.
    Bialous SA; Fox BJ; Glantz SA
    Am J Public Health; 2001 Jan; 91(1):62-7. PubMed ID: 11189827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.